✦ LIBER ✦

Long-term outcome of nonmyeloablative allogeneic transplantation in patients with high-risk multiple myeloma

✍ Scribed by Gerull, S; Goerner, M; Benner, A; Hegenbart, U; Klein, U; Schaefer, H; Goldschmidt, H; Ho, A D

Book ID: 110014793
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 177 KB
Volume: 36
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1705161

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcome of unrelated transplants in pati

✍ Ballen, K K; King, R; Carston, M; Kollman, C; Nelson, G; Lim, S; Reece, D; Giral 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 131 KB

Early recurrence of rheumatoid arthritis

Early recurrence of rheumatoid arthritis after nonmyeloablative allogeneic blood stem cell transplantation in a patient with multiple myeloma

✍ Tapprich, C; Fenk, R; Schneider, P; Bernhardt, A; Haas, R; Kobbe, G 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 124 KB

Long-term outcomes following myeloablati

Long-term outcomes following myeloablative allogeneic transplantation for multiple myeloma compared to autologous transplantation and the impact of graft-versus-myeloma effect

✍ Khaled, Y; Mellacheruvu, S; Reddy, P; Peres, E; Mineishi, S 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 114 KB

Outcome after autologous and allogeneic

Outcome after autologous and allogeneic stem cell transplantation for patients with multiple myeloma: impact of graft-versus-myeloma effect

✍ Alyea, E; Weller, E; Schlossman, R; Canning, C; Mauch, P; Ng, A; Fisher, D; Grib 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 151 KB

Impact of dexamethasone responsiveness o

Impact of dexamethasone responsiveness on long term outcome in patients with newly diagnosed multiple myeloma

✍ Shirshendu Sinha; S. Vincent Rajkumar; Martha Q. Lacy; Suzanne R. Hayman; Franci 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 210 KB

Allogenic hematopoietic stem-cell transp

Allogenic hematopoietic stem-cell transplantation with reduced-intensity conditioning in patients with refractory and recurrent multiple myeloma : Long-term follow-up

✍ Avichai Shimoni; Izhar Hardan; Francis Ayuk; Georgia Schilling; Djorde Atanackov 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

## Abstract ## BACKGROUND: Allogeneic stem cell transplantation (SCT) with myeloablative conditioning is potentially curative therapy for myeloma, but is reportedly associated with a high risk of nonrecurrence mortality (NRM). Reduced‐intensity conditioning (RIC) allows for the reduction of NRM, b